eFFECTOR Therapeutics (OTC:EFTR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does eFFECTOR Therapeutics (EFTR) operate in?

eFFECTOR Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.

eFFECTOR Therapeutics Stock (OTC: EFTR) stock price, news, charts, stock research, profile.

Open	$0.00
Close	$0.00
Volume / Avg.	1.67K / 21.90K
Day Range	$0.00 - $0.00
52 Wk Range	0.00 - 17.75
Market Cap	$940.00
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher

Avi Kapoor

Why eFFECTOR Therapeutics (EFTR) Shares Are Down Over 70%

EFFECTOR Therapeutics shares are trading lower by 74% during Monday's session. The company announced that it has terminated its employees and will wind down its operations.

Henry Khederian

Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results

U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88. The S&P 500 also fell, dropping, 0.28% to 5,197.03.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.00
Close	$0.00
Volume / Avg.	1.67K / 21.90K
Day Range	$0.00 - $0.00
52 Wk Range	0.00 - 17.75
Market Cap	$940.00
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy eFFECTOR Therapeutics (EFTR) stock?

You can purchase shares of eFFECTOR Therapeutics (OTCEM:EFTR) through any online brokerage.

View our list of the best stock brokerages

Who are eFFECTOR Therapeutics (EFTR) competitors?

There are no as such competitors for eFFECTOR Therapeutics.

What is the forecast, or price target, for eFFECTOR Therapeutics (EFTR) stock?

eFFECTOR Therapeutics has a consensus price target of $9.38.

What is the current price for eFFECTOR Therapeutics (EFTR)?

The stock price for eFFECTOR Therapeutics (OTCEM: EFTR) is $0.0783 last updated July 5, 2024 at 4:00 PM EDT.

Does eFFECTOR Therapeutics (EFTR) pay a dividend?

There are no upcoming dividends for eFFECTOR Therapeutics.

When is eFFECTOR Therapeutics (OTCEM:EFTR) reporting earnings?

eFFECTOR Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is eFFECTOR Therapeutics (EFTR) going to split?

There is no upcoming split for eFFECTOR Therapeutics.

What sector and industry does eFFECTOR Therapeutics (EFTR) operate in?

eFFECTOR Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.

Comments

eFFECTOR Therapeutics

eFFECTOR Therapeutics (EFTR) Forecast